Alvotech Completes Second Round of a US$100 Million Private Placement BioTech March 15, 2021 Multinational biopharmaceutical company Alvotech has successfully completed a second round of its US$100 million private placement, for US$35 million. The first…
Alvotech and Cipla Gulf Expand Partnership for Commercialization of Biosimilars in Australia and New Zealand BioTech March 4, 2021 Multinational biopharmaceutical company Alvotech and Gulf FZ LCC (“Cipla Gulf”), subsidiary of Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred…
